Interesting data from a McKinsey & Company report stating that the anticipated impact of generative AI across the pharma industry will be $60-110 billion, which is 3%-5% of total industry revenue! ISPOR #GenerativeAI CQ fluency

Interesting to see what ISPOR attendees see as the biggest challenges when it comes to "patient engagement" CQ fluency #patientengagement #Diversity and #diversityandinclusion

For meaningful patient engagement we need to value all voices. Besides relationship building, communication and education, foster trust, self-awareness and acceptance.CQ fluency ISPOR #patientcentricity @diversityandinclusion

Interesting consideration posed at #ISPOREurope on Patient and public involvement and engagement (PPIE) by The University of Sheffield : are we aiming for the impossible and if we don't, are we going to be exposed to criticism? CQ fluency

The afternoon of the first day of ISPOR ongoing. HEOR at the Nexus of Policy and Science. Great enlightning introductory and advanced session on a number of themes. Happy attending part II!

Talking about Diversity in patient recruitment during ISPOR. According to the US National Health Council, the Asian population in the US doubled from 11.9 mio in 2020 to 22.4 mio in 2022 and is expected to reach 46 mio by 2060. CQ fluency GMR-Austin

Very excited to hear what lies ahead, ISPOR !

From Parexel a refresher on the definition of Evergreen (aka Living) Evidence: the continuous integration of new data allowing for dynamic decision-making that reflects real-world health care outcomes over time. ISPOR

Did you know that according to Parexel approximately 70% of adults in the USA have concerns about the increase use of AI in healthcare and that younger patients are more willing to engage? ISPOR CQ fluency

The caveats of SLR (Systematic Literature Review): lack of transparency used by AI for decision-making (black-box), AI dependency on biasness in the training set and ethical implications. ISPOR CQ fluency

Last session of day I at ISPOR with representatives from Bayer | Pharmaceuticals Gates Medical Research Institute and University of Birmingham. CQ fluency

Looking forward to yet another interesting day at 2023 #ISPOREurope with the keynote on the new pharma regulation starting soon.

#ISPOREurope President of ISPOR sharing the presidential vision on thee 2024 strategy. Value driven innovation, increase passion in the different disciplines, training, education and more #healthcare #HEOR

The EU pharmaceutical legislation originates from 1965, and was updated in 2004. In 2020 in light of COVID-19 and as part of the EU pharma strategy, the Commission planned another revision of the general EU legislation of medicines for human use. #ISPOREurope #healthcare #HEOR

For the 2020 EU legislation revision for pharma, 4 pillars were identified: 1. make medicines affordable to all; 2. foster sustainability and competitive innovation; 3. strong EU voice globally and 4. increased preparedness for crises. #ISPOREurope #healthcare #HEOR

The new EU pharmaceutical legislation will be guided by 3 A's, i.e. Affordability, Accessability and Availabilitym and 3 S's: Sustainability, Solidarity and Social contract #HEOR #CQfluency #ISPOREurope

Guilty until proven innocent. Thank you Sweden…❤️

Looking forward to attending this year's Annual ISOQOL conference in Cologne for the next three days, October 13-16. Great agenda and roster of speakers. Looking also forward to learning a lot and meeting new people

Groenteman is te irritant voor woorden. Hij snapt er helemaal niets van en hinnikt inderdaad overal doorheen!